Services & Solutions

Vaccine Product Development & Manufacturing

WuXi Vaccines is a global, integrated CDMO for vaccine and prophylactic antibody development and manufacturing. With leading production systems spanning mammalian, microbial, viral, and mRNA capabilities, we accelerate clinical and market access to vaccine and prophylactic antibody products. As part of our commitment to global collaboration, we are proud to support small startups and multinational corporations alike in bringing more preventive products to the market more cost-effectively to advance global health initiatives.

With the experience and technology to develop and manufacture many types of vaccines, including monoclonal antibodies (mAbs), recombinant proteins, virus-like particles (VLPs), outer membrane vesicles (OMVs), viral vectors, live attenuated viruses, and conjugated vaccines, we strive to empower global partners to deliver critical vaccines anywhere in the world. With our technical expertise, broad regulatory knowledge, premium quality system, advanced CMC capabilities, mammalian and microbial production systems, and extensive GMP manufacturing capacity, WuXi Vaccines is your trusted CDMO partner from development to large-scale commercial production and distribution.

End-to-End Capabilities

Through comprehensive testing and manufacturing services, we support the development of vaccine and prophylactic antibody products at any stage. From initial vector screening or protein generation to late-stage manufacturing, we offer the entire range of capabilities, such as developability assessment, material generation, cell line development and banking, analytical development, drug substance (DS) process development, drug product formulation and process development, clinical and commercial manufacturing, lot release and stability testing, and regulatory filing support.